1.Comparison of the safety of docetaxel combined with carboplatin regimen and epirubicin combined with cyclophosphamide sequential docetaxel regimen in phase Ⅲ clinical study of negative breast cancer
ming De LV ; juan Bao FU ; ming Chao WANG ; Sheng LV ; xia Cai ZU
Chinese Journal of Biochemical Pharmaceutics 2017;37(10):177-178
Objective To compare the clinical efficacy and safety of docetaxel combined with carboplatin (TP) and epirubicin combined with cyclophosphamide sequential docetaxel (EC-T) adjuvant in the treatment of three negative breast cancer in phase III . Methods 62 cases of three negative breast cancer patients in phase III from May 2012 to October 2016 were selected and randomly divided into the control group and the experimental group, with 31 patients in each group. The control group was treated with epirubicin combined with cyclophosphamide and sequential docetaxel, and the experimental group was treated with docetaxel and carboplatin. The clinical indicators were compared and analyzed. Results There was no significant difference in the recent remission rate (77.42%) between the experimental group and the control group (74.19%). Two groups of patients with adverse reactions were restored within one month. There were 10 cases of WBC decrease in the experimental group, with the incidence rate of 32.25%. There were 18 cases of WBC decrease in the control group, the incidence rate was 58.06%, the difference was statistically significant (P<0.05). Conclusion Docetaxel combined with carboplatin and epirubicin adjuvant combined with cyclophosphamide than star sequential docetaxel in the treatment of three patients with negative breast cancer stage III were tolerated, TP occurred leukopenia and alopecia with low probability.
2.Change of CMTM7 expression, a potential tumor suppressor, is associated with poor clinical outcome in human non-small cell lung cancer.
Qiang LIU ; Yu SU ; Guan-Chao JIANG ; Zu-Li ZHOU ; Bao-Cai LIU ; Liang BU ; Fan YANG ; Fang QIAO ; Jun WANG
Chinese Medical Journal 2013;126(16):3006-3012
BACKGROUNDCKLF-like MARVEL transmembrane domain-containing 7 (CMTM7) located at 3p22.3, is a frequent deletion site and a tumor suppressor gene (TSG) locus in many cancer, which suggests CMTM7 may be a potential TSG. The aim of this study was to investigate the correlations of CMTM7 expression and survival rate in patients with non-smallcell lung cancer (NSCLC).
METHODSSurgical specimens of 180 cases with pathologically confirmed NSCLC were grouped into 18 tissue microarray slides. CMTM7 expression in these specimens were detected by immunohistochemistry staining and representative cases were confirmed by Western blotting. Univariate and multivariate analyses were performed to identify the association of CMTM7 expression with pathological features and survival of patients with NSCLC.
RESULTSA total of 78.9% of the 180 patients had variations of CMTM7 protein expression, either up-regulated or down-regulated. Univariate analysis showed that the patients' survival rate after surgery was highly correlated with CMTM7 expression (P = 0.0091). In addition, prognostic factors were examined by multivariate Cox regression analysis, and results suggested that CMTM7 expression was a unique prognostic factor in NSCLC survival.
CONCLUSIONSThe CMTM7 expression may be related to survival of patients with NSCLC and a unique prognostic factor. CMTM7 may play an important role in NSCLC development.
Adult ; Aged ; Aged, 80 and over ; Carcinoma, Non-Small-Cell Lung ; chemistry ; mortality ; pathology ; Chemokines ; analysis ; genetics ; physiology ; Female ; Humans ; Lung Neoplasms ; chemistry ; mortality ; pathology ; MARVEL Domain-Containing Proteins ; analysis ; genetics ; physiology ; Male ; Middle Aged ; Prognosis ; Proportional Hazards Models ; Tissue Array Analysis ; Tumor Suppressor Proteins ; analysis ; genetics ; physiology
3.Recombinant-attenuated Salmonella Pullorum strain expressing the hemagglutinin-neuraminidase protein of Newcastle disease virus (NDV) protects chickens against NDV and Salmonella Pullorum challenge
Ke DING ; Ke SHANG ; Zu Hua YU ; Chuan YU ; Yan Yan JIA ; Lei HE ; Cheng Shui LIAO ; Jing LI ; Chun Jie ZHANG ; Yin Ju LI ; Ting Cai WU ; Xiang Chao CHENG
Journal of Veterinary Science 2018;19(2):232-241
Newcastle disease virus (NDV) and Salmonella Pullorum have significant damaging effects on the poultry industry, but no previous vaccine can protect poultry effectively. In this study, a recombinant-attenuated S. Pullorum strain secreting the NDV hemagglutinin-neuraminidase (HN) protein, C79-13ΔcrpΔasd (pYA-HN), was constructed by using the suicide plasmid pREasd-mediated bacteria homologous recombination method to form a new bivalent vaccine candidate against Newcastle disease (ND) and S. Pullorum disease (PD). The effect of this vaccine candidate was compared with those of the NDV LaSota and C79-13ΔcrpΔasd (pYA) strains. The serum hemagglutination inhibition antibody titers, serum immunoglobulin G (IgG) antibodies, secretory IgA, and stimulation index in lymphocyte proliferation were increased significantly more (p < 0.01) in chickens inoculated with C79-13ΔcrpΔasd (pYA-HN) than with C79-13ΔcrpΔasd (pYA) but were not significantly increased compared with the chickens immunized with the LaSota live vaccine (p > 0.05). Moreover, the novel strain provides 60% and 80% protective efficacy against the NDV virulent strain F48E9 and the S. Pullorum virulent strain C79-13. In summary, in this study, a recombinant-attenuated S. Pullorum strain secreting NDV HN protein was constructed. The generation of the S. Pullorum C79-13ΔcrpΔasd (pYA-HN) strain provides a foundation for the development of an effective living-vector double vaccine against ND and PD.
Animals
;
Antibodies
;
Bacteria
;
Chickens
;
Hemagglutination
;
HN Protein
;
Homologous Recombination
;
Immunoglobulin A, Secretory
;
Immunoglobulin G
;
Lymphocytes
;
Methods
;
Newcastle disease virus
;
Newcastle Disease
;
Plasmids
;
Poultry
;
Salmonella
;
Suicide
;
Vaccines
4.2-Hexyl-4-Pentylenic Acid (HPTA) Stimulates the Radiotherapy-induced Abscopal Effect on Distal Tumor through Polarization of Tumor-associated Macrophages.
Wen Hua DUAN ; Li Ya JIN ; Zu Chao CAI ; David LIM ; Zhi Hui FENG
Biomedical and Environmental Sciences 2021;34(9):693-704
Objective:
The aim of this study was to explore the effects of 2-hexyl-4-pentylenic acid (HPTA) in combination with radiotherapy (RT) on distant unirradiated breast tumors.
Methods:
Using a rat model of chemical carcinogen (7,12-dimethylbenz[a]anthracene,DMBA)-induced breast cancer, tumor volume was monitored and treatment response was evaluated by performing HE staining, immunohistochemistry, immunofluorescence, qRT-PCR, and western blot analyses.
Results:
The results demonstrated that HPTA in combination with RT significantly delayed the growth of distant, unirradiated breast tumors. The mechanism of action included tumor-associated macrophage (TAM) infiltration into distant tumor tissues, M1 polarization, and inhibition of tumor angiogenesis by IFN-γ.
Conclusion
The results suggest that the combination of HPTA with RT has an abscopal effect on distant tumors
Animals
;
Antineoplastic Agents/therapeutic use*
;
Cell Proliferation/radiation effects*
;
Combined Modality Therapy
;
Cytokines/immunology*
;
Fatty Acids, Unsaturated/therapeutic use*
;
Female
;
Mammary Neoplasms, Experimental/radiotherapy*
;
Rats
;
Tumor-Associated Macrophages/radiation effects*